UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 255

Sortiert nach

Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels

Scientific reports, 2015-11, Vol.5 (1), p.16872, Article 16872

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.228-228

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E440-E440

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

Cancer chemotherapy and pharmacology, 2013-05, Vol.71 (5), p.1173-1182

2013

Link zum Volltext

Verfügbarkeit prüfen

Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?

Cancer Immunology, Immunotherapy, 2006-08, Vol.55 (8), p.891-899

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of Household Size and Age on Consumer Perceptual Factors Influencing Store Brand Purchase Intention: A Multi-group Analysis

South Asian journal of management, 2023-11, Vol.30 (3), p.119-140

2023

Link zum Volltext

Verfügbarkeit prüfen

P21.09 Does Duration of Maintenance Durvalumab Matter? Relationship between Length of Durvalumab Therapy and PFS

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S367-S367

2021

Link zum Volltext

Verfügbarkeit prüfen

Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males

Occupational and environmental medicine (London, England), 2008-10, Vol.65 (10), p.647-654

2008

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Carboplatin, Paclitaxel, and Selenomethionine in Combination With Radiation for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase 2 Multicenter Trial

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S76-S77

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S76-S76

2013

Link zum Volltext

Verfügbarkeit prüfen

MCM2 Is an Independent Predictor of Survival in Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4259-4266

2001

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic Pneumonitis Rates Among Patients with Stage III Non-Small Cell Lung Cancer Receiving Adjuvant Durvalumab

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e17-e17

2023

Link zum Volltext

Verfügbarkeit prüfen

P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S337-S338

2023

Link zum Volltext

Verfügbarkeit prüfen

Re-irradiation May be a Viable Option for Patients with Local Recurrence after a Definitive Course of Radiation Therapy in Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S533-S533

2010

Link zum Volltext

Verfügbarkeit prüfen

P2.06-08 Phase I/II Study of Rucaparib and Pembrolizumab Maintenance in Stage IV NSCLC after Carboplatin, Pemetrexed, Pembrolizumab

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S320

2023

Link zum Volltext

Verfügbarkeit prüfen

Hormone Replacement Therapy as a Risk Factor for Non-Small Cell Lung Cancer: Results of a Case-Control Study

Oncology, 2007-01, Vol.73 (5-6), p.305-310

2007

Link zum Volltext

Verfügbarkeit prüfen

Personalized High Dose Radiation (>70 Gy) Is Significantly Associated with Better Local Regional Control and Overall Survival in Non-small Cell Lung Cancer Treated with Concurrent Chemoradiation

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S594-S594

2011

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Chemoradiotherapy Increases the Risk of Radiation-Induced Pericardial Effusion in Patients with Locally Advanced Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S501-S501

2010

Link zum Volltext

Verfügbarkeit prüfen

Nuclear or cytoplasmic expression of survivin: What is the significance?

International journal of cancer, 2005-04, Vol.114 (4), p.509-512

2005

Link zum Volltext

Verfügbarkeit prüfen

P57.03 Cellular Engagement and Interaction in the Tumor Microenvironment (TME) Predicts Response to ICI in Metastatic NSCLC

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1137-S1138

2021

Link zum Volltext

Verfügbarkeit prüfen

Can We Deliver High Dose Radiation in 6 Weeks with Concurrent Chemotherapy in Stage III Non-small Cell Lung Cancer?

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S35-S35

2010

Link zum Volltext

Verfügbarkeit prüfen

The Additional Value of V/Q SPECT over Q SPECT Alone for Pulmonary Function Mapping before, during and after Radiotherapy in Patients with Non–small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S448-S448

2009

Link zum Volltext

Verfügbarkeit prüfen

No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: results of a randomized clinical trial

The Journal of thoracic and cardiovascular surgery, 2003-06, Vol.125 (6), p.1432-1437

2003

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Post-Treatment Hospitalization in Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT) for Centrally Located Tumors

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E501-E501

2019

Link zum Volltext

Verfügbarkeit prüfen

P78.05 Patterns of irAE During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S639-S640

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(229)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(87)
Humans
(73)
Biological And Medical Sciences
(53)
Male
(52)
Female
(46)
Medical Sciences
(44)
Middle Aged
(36)
Oncology
(34)
Adult
(33)
Technology
(30)
Aged
(28)
Chemistry
(21)
Physical Sciences
(17)
Animals
(16)
Pneumology
(16)
Tumors Of The Respiratory System And Mediastinum
(16)
Lung Neoplasms - Mortality
(15)
Materials Science
(15)
Pharmacology. Drug Treatments
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels

Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer

A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC)

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?

Effect of Household Size and Age on Consumer Perceptual Factors Influencing Store Brand Purchase Intention: A Multi-group Analysis

P21.09 Does Duration of Maintenance Durvalumab Matter? Relationship between Length of Durvalumab Therapy and PFS

Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males

Concurrent Carboplatin, Paclitaxel, and Selenomethionine in Combination With Radiation for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase 2 Multicenter Trial

A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

MCM2 Is an Independent Predictor of Survival in Patients With Non–Small-Cell Lung Cancer

Symptomatic Pneumonitis Rates Among Patients with Stage III Non-Small Cell Lung Cancer Receiving Adjuvant Durvalumab

P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer

Re-irradiation May be a Viable Option for Patients with Local Recurrence after a Definitive Course of Radiation Therapy in Non-small Cell Lung Cancer

P2.06-08 Phase I/II Study of Rucaparib and Pembrolizumab Maintenance in Stage IV NSCLC after Carboplatin, Pemetrexed, Pembrolizumab

Hormone Replacement Therapy as a Risk Factor for Non-Small Cell Lung Cancer: Results of a Case-Control Study

Personalized High Dose Radiation (>70 Gy) Is Significantly Associated with Better Local Regional Control and Overall Survival in Non-small Cell Lung Cancer Treated with Concurrent Chemoradiation

Concurrent Chemoradiotherapy Increases the Risk of Radiation-Induced Pericardial Effusion in Patients with Locally Advanced Non-small Cell Lung Cancer

Nuclear or cytoplasmic expression of survivin: What is the significance?

P57.03 Cellular Engagement and Interaction in the Tumor Microenvironment (TME) Predicts Response to ICI in Metastatic NSCLC

Can We Deliver High Dose Radiation in 6 Weeks with Concurrent Chemotherapy in Stage III Non-small Cell Lung Cancer?

The Additional Value of V/Q SPECT over Q SPECT Alone for Pulmonary Function Mapping before, during and after Radiotherapy in Patients with Non–small Cell Lung Cancer

No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: results of a randomized clinical trial

Predictors of Post-Treatment Hospitalization in Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT) for Centrally Located Tumors

P78.05 Patterns of irAE During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome

Suchergebnisse filtern